HC
SPPI

Henshaw Capital’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Henshaw Capital’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-20,009
Closed -$75K – 362
2021
Q2 		$75K Hold
20,009
– – ﹤0.01% 349
2021
Q1 		$65.2K Hold
20,009
– – ﹤0.01% 345
2020
Q4 		$68.2K Hold
20,009
– – 0.01% 340
2020
Q3 		$81.6K Buy
20,009
+6,921
+53% +$26.3K 0.01% 312
2020
Q2 		$44.2K Hold
13,088
– – ﹤0.01% 310
2020
Q1 		$30.5K Buy
+13,088
New +$35.8K ﹤0.01% 280
2019
Q4 		– Sell
-12,291
Closed -$102K – 306
2019
Q3 		$102K Buy
12,291
+2,238
+22% +$18.1K 0.01% 281
2019
Q2 		$86.6K Hold
10,053
– – 0.01% 289
2019
Q1 		$107K Hold
10,053
– – 0.01% 281
2018
Q4 		$88K Buy
+10,053
New +$128K 0.01% 269

Other funds holding SPPI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Henshaw Capital's SPPI Position: Q3 2021 in Review

Henshaw Capital sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2021, closing a stake of 20,009 shares — an estimated $75K sold.

Henshaw Capital first reported a position in SPPI in Q4 2018 and held it in 10 quarters. The position peaked at $107K in Q1 2019. 147 funds tracked by Wall St. Rank hold SPPI as of Q3 2021.

  • Henshaw Capital reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2021 after selling out during the quarter.
  • Henshaw Capital sold 20,009 Spectrum Pharmaceuticals Inc shares in Q3 2021, an estimated $75K.
  • Henshaw Capital first reported a position in Spectrum Pharmaceuticals Inc in Q4 2018 and held it in 10 quarters.
  • Henshaw Capital's Spectrum Pharmaceuticals Inc position peaked at $107K in Q1 2019.
  • 147 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2021.

Based on Henshaw Capital's 13F filing for Q3 2021, filed 28 May 2026.